Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Th1/Th2 balance in autoimmunity

B Charlton1, K J Lafferty

  • 1John Curtin School of Medical Research, Australian National University, Canberra.

Current Opinion in Immunology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2017
Same author

Characterization of Seven Outbreaks of Hemorrhagic Hepatopathy Syndrome in Commercial Pullets Following the Administration of a Salmonella Enteritidis Bacterin in California.

Avian diseases·2016
Same author

Spatial and temporal epidemiology of infectious laryngotracheitis in central California: 2000-2012.

Avian diseases·2015
Same author

Retrospective study of turkey viral hepatitis in California turkey flocks, 2000-2012.

Avian diseases·2014
Same author

Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.

The European respiratory journal·2011
Same author

The isolation of exotic Newcastle disease (END) virus from nonpoultry avian species associated with the epidemic of END in chickens in southern California: 2002-2003.

Avian diseases·2005
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

The balance between T-helper type 1 (Th1) and T-helper type 2 (Th2) CD4+ T-cells impacts autoimmune disease development and severity. Modulating this Th1/Th2 balance offers a potential strategy for controlling autoimmune conditions.

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • T-cell Biology

Background:

  • Autoimmune diseases arise from complex T-cell responses.
  • T-helper type 1 (Th1) and T-helper type 2 (Th2) CD4+ T-cells play critical roles in immune responses.
  • The balance between Th1 and Th2 cells influences disease development and clinical manifestation.

Purpose of the Study:

  • To investigate the role of Th1 and Th2 CD4+ T-cell responses in autoimmune disease.
  • To explore how the balance between Th1 and Th2 cells affects disease pathogenesis.
  • To identify potential therapeutic strategies for autoimmune disease control.

Main Methods:

  • Analysis of CD4+ T-cell responses in autoimmune models.
  • Investigation of the influence of costimulatory molecules on Th1/Th2 development.

Related Experiment Videos

  • Evaluation of the regulatory capacity of autoreactive Th2 cells on Th1 cells in vivo.
  • Main Results:

    • The relative contribution of Th1 and Th2 cells significantly influences whether an autoimmune response leads to clinical disease.
    • This influence varies depending on whether the disease is cell-mediated or antibody-mediated.
    • Autoreactive Th2 CD4+ T cells can modulate the activity of pathogenic Th1 CD4+ T cells.

    Conclusions:

    • The balance of Th1/Th2 CD4+ T-cell responses is a key determinant in autoimmune disease.
    • Modulating the Th1/Th2 balance presents a potential therapeutic avenue for autoimmune disease management.
    • Understanding the factors influencing Th1/Th2 development is crucial for targeted autoimmune therapies.